TORLEY HELEN (PRESIDENT AND CEO) sold 6.6% of their position (50K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.85M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$12.07
Trade value
$241.40K
% of position
Common Stock
Shares
−2.55K
Price / share
$74.88
Trade value
$191.02K
% of position
Common Stock
Shares
−9.66K
Price / share
$75.94
Trade value
$733.54K
% of position
Common Stock
Shares
−7.79K
Price / share
$76.73
Trade value
$597.76K
% of position
Common Stock
Shares
+20K
Price / share
$12.07
Trade value
$241.40K
% of position
Common Stock
Shares
−9.90K
Price / share
$76.94
Trade value
$761.67K
% of position
Common Stock
Shares
−10.10K
Price / share
$77.54
Trade value
$783.15K
% of position
Common Stock
Shares
+10K
Price / share
$12.07
Trade value
$120.70K
% of position
Common Stock
Shares
−5.38K
Price / share
$78.38
Trade value
$421.37K
% of position
Common Stock
Shares
−4.62K
Price / share
$78.94
Trade value
$365K
% of position
Net shares
+0.00
Net value
-$3.25M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | M · Option Exercise | +20K | $12.07 | $241.40K | 2.8% | 708.72K | 728.72K |
| Common Stock Direct | 2/3/2026 | S · Sale | −2.55K | $74.88 | $191.02K | 0.4% | 728.72K | 726.17K |
| Common Stock Direct | 2/3/2026 | S · Sale | −9.66K | $75.94 | $733.54K | 1.3% | 726.17K | 716.51K |
| Common Stock Direct | 2/3/2026 | S · Sale | −7.79K | $76.73 | $597.76K | 1.1% | 716.51K | 708.72K |
| Common Stock Direct | 2/4/2026 | M · Option Exercise | +20K | $12.07 | $241.40K | 2.8% | 708.72K | 728.72K |
| Common Stock Direct | 2/4/2026 | S · Sale | −9.90K | $76.94 | $761.67K | 1.4% | 728.72K | 718.82K |
| Common Stock Direct | 2/4/2026 | S · Sale | −10.10K | $77.54 | $783.15K | 1.4% | 718.82K | 708.72K |
| Common Stock Direct | 2/5/2026 | M · Option Exercise | +10K | $12.07 | $120.70K | 1.4% | 708.72K | 718.72K |
| Common Stock Direct | 2/5/2026 | S · Sale | −5.38K | $78.38 | $421.37K | 0.7% | 718.72K | 713.34K |
| Common Stock Direct | 2/5/2026 | S · Sale | −4.62K | $78.94 | $365K | 0.6% | 713.34K | 708.72K |
| Total | +0.00 | -$3.25M | ||||||
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
12.07
Held after
231.92K
Exercisable
—
Option to Purchase Common Stock
Common Stock
20K shares
Shares
−20K
Strike price
12.07
Held after
211.92K
Exercisable
—
Option to Purchase Common Stock
Common Stock
10K shares
Shares
−10K
Strike price
12.07
Held after
201.92K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock20K shares | 2/3/2026 | M · Option Exercise | −20K | 12.07 | — | 231.92K |
| Option to Purchase Common Stock Direct | Common Stock20K shares | 2/4/2026 | M · Option Exercise | −20K | 12.07 | — | 211.92K |
| Option to Purchase Common Stock Direct | Common Stock10K shares | 2/5/2026 | M · Option Exercise | −10K | 12.07 | — | 201.92K |